Drug company fined for excessive hospitalityBMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7283.382/b (Published 17 February 2001) Cite this as: BMJ 2001;322:382
- Tony Sheldon
In a legal test case Merck Sharp and Dohme has become the first pharmaceutical company in the Netherlands to be prosecuted for entertaining doctors excessively, contrary to the Dutch marketing code for prescription-only drugs.
The company was fined a total of 95000 guilders (£27500; $41000) relating to 19 events promoting its new antimigraine drug rizatriptan (Maxalt). The court found that hospitality had not been kept within reasonable limits, nor was there a reasonable division between the scientific part of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial